BIOMAT Database Logo BIOMAT Database Logo

Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study. 1973

V Predescu, and T Ciurezu, and G Timofte, and I Roman

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009497 Neurotic Disorders Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment. Neuroses,Psychoneuroses,Disorder, Neurotic,Disorders, Neurotic,Neurotic Disorder
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness

Related Publications

V Predescu, and T Ciurezu, and G Timofte, and I Roman
Symptomatic relief of neurotic symptoms with tybamate: a doube-blind, placebo-controlled study.
January 1967, Acta psychiatrica Scandinavica,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study.
January 1984, Neuropsychobiology,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
[Flupentixol (Fluanxol) or diazepam in the treatment of various psychosomatic conditions. A controlled double-blind multicenter study].
December 1986, Ugeskrift for laeger,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
Iprindole in depressive states: a controlled, double-blind study.
January 1972, Current medical research and opinion,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
[Double-blind comparison of parsalmide and diazepam in anxious and depressive neurotic syndromes].
October 1976, Minerva medica,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
Oral salbutamol for symptomatic relief in mild bronchiolitis a double blind randomized placebo controlled trial.
July 2008, Indian pediatrics,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
February 1989, Clinical neuropharmacology,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
Treatment of depressive anxiety states associated with psychosomatic symptoms. A double-blind multicentre clinical study: mianserin versus melitracen-flupentixol.
January 1983, Acta psychiatrica Belgica,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
Vitamin E is ineffective for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo controlled study.
October 2001, Annals of the rheumatic diseases,
V Predescu, and T Ciurezu, and G Timofte, and I Roman
Loperamide in the symptomatic control of chronic diarrhoea. Double-blind placebo-controlled study.
October 1975, Annals of clinical research,
Copied contents to your clipboard!